Proportion of Prescribed Conditions & Latest Patient Approval Numbers
To date, the TGA has approved SAS applications including, but not limited to, the following indications:
- chemotherapy-induced nausea and vomiting
- refractory paediatric epilepsy
- palliative care indications
- cancer pain
- neuropathic pain
- spasticity from neurological conditions
- anorexia and wasting associated with chronic illness (such as cancer)
A break down of proportion of these conditions TGA has approved (from 2020)
Source: www.nps.org.au/australian-prescriber/articles/prescribing-medicinal-cannabis
Latest Australian Medical Cannabis Patient Approval Data
Source: https://www.tga.gov.au/medicinal-cannabis-role-tga
